Key Metrics
CiteScore 

6.8
H-Index 

46
Impact Factor 

< 5
SJR 

Q1Pharmacology (medical)

SNIP 

1.42
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 15 |
| Editorial Review Process | Open peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Respiratory Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Respiratory Disease
Lung organoids as emerging models in idiopathic pulmonary fibrosis research: Current applications, challenges, and future directions
- 1 Aug 2026
- Therapeutic Advances in Respiratory Disease
Surgical management of refractory massive hemoptysis from pulmonary artery pseudoaneurysm due to Streptococcus constellatus: a rare case report and literature review
- 29 Jul 2026
- Therapeutic Advances in Respiratory Disease
Rural and urban environmental exposures and the risk of progressive pulmonary fibrosis
- 28 Jul 2026
- Therapeutic Advances in Respiratory Disease
The prevalence and unique clinical features of CPFE among patients with connective tissue disease\u2013associated interstitial lung disease: a retrospective, real-world study
- 27 Jul 2026
- Therapeutic Advances in Respiratory Disease
Association between organophosphate insecticide metabolites and lung function in U.S. adults: NHANES 2011\u20132012
- 27 Jul 2026
- Therapeutic Advances in Respiratory Disease
Exploring the lived experiences of individuals with cystic fibrosis after the implementation of elexacaftor/tezacaftor/ivacaftor for treatment
- 25 Jul 2026
- Therapeutic Advances in Respiratory Disease
Lung organoids as emerging models in idiopathic pulmonary fibrosis research: Current applications, challenges, and future directions
- 1 Aug 2026
- Therapeutic Advances in Respiratory Disease
Surgical management of refractory massive hemoptysis from pulmonary artery pseudoaneurysm due to Streptococcus constellatus: a rare case report and literature review
- 29 Jul 2026
- Therapeutic Advances in Respiratory Disease
Rural and urban environmental exposures and the risk of progressive pulmonary fibrosis
- 28 Jul 2026
- Therapeutic Advances in Respiratory Disease
The prevalence and unique clinical features of CPFE among patients with connective tissue disease\u2013associated interstitial lung disease: a retrospective, real-world study
- 27 Jul 2026
- Therapeutic Advances in Respiratory Disease
Association between organophosphate insecticide metabolites and lung function in U.S. adults: NHANES 2011\u20132012
- 27 Jul 2026
- Therapeutic Advances in Respiratory Disease
Exploring the lived experiences of individuals with cystic fibrosis after the implementation of elexacaftor/tezacaftor/ivacaftor for treatment
- 25 Jul 2026
- Therapeutic Advances in Respiratory Disease